Status: Recruiting
Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer
The primary objective of this study is to evaluate the feasibility, safety, and efficacy of personalized T-cell therapy based on tumor neoantigens in patients with advanced colorectal cancer, so as to provide a novel individualized therapeutic strategy for such patients.
Participants needed: 20
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Ying Yuan, MDUpdated: Apr 1, 2026Locations: 1
Eligibility criteria
Aged ≥ 18 years and ≤ 70 years; [+8]
Unwilling to sign the informed consent form. [+13]